secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001628280-24-035842
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q2 net revenue $33.7M (record), net income $0.7M (+65% YoY); reaffirms FY24 high-single-digit growth
--------------------------------------------------------------------------------

- Net revenues $33.7M (+6% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M ($0.02) prior year.
- Patient Services rev $20.2M (+5%), Device Solutions $13.5M (+8%); overall gross margin 49.5% (down 0.4%).
- Adjusted EBITDA $6.1M (18.0% margin), up 5.4% YoY; operating cash flow $2.7M (+17%).
- Device Solutions gross margin fell 8.1% to 24.0% due to $0.6M error correction and unfavorable mix.
- Reaffirmed FY24 guidance: high-single-digit revenue growth, Adjusted EBITDA margin in high-teens.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828024035842/0001628280-24-035842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828024035842/infu-20240808.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-035842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer